source
- Medicare’s new $50 GLP‑1 weight‑loss drug program may create barriers for patients, warns expertsMedicare has launched a program that caps out‑of‑pocket costs for GLP‑1 weight‑loss medicines such as Wegovy, Zepbound and Foundayo at $50 a month for eligible beneficiaries. The initiative is inte…
- Abbott partners with Google Health to add AI-driven insights to its Lingo glucose wearableAbbott and Google Health announced a partnership that will combine Abbott's Lingo consumer glucose wearable with Google Health's artificial‑intelligence platform. The integration will let Lingo us…